JCI
44
2
UA
35
-13
VIX
11
-2
BEN
41
-9
FFIV
64
2
FLS
75
8
PPL
67
-2
QRVO
34
-4
REGN
65
2
HAL
50
4
MTCH
44
-2
MAS
51
-11
ABBV
64
4
HST
39
-5
MMC
70
2
RL
76
3
KSS
47
-4
UNM
70
2
FOX
50
2
TEL
83
-2
JCI
44
2
UA
35
-13
VIX
11
-2
BEN
41
-9
FFIV
64
2
FLS
75
8
PPL
67
-2
QRVO
34
-4
REGN
65
2
HAL
50
4
MTCH
44
-2
MAS
51
-11
ABBV
64
4
HST
39
-5
MMC
70
2
RL
76
3
KSS
47
-4
UNM
70
2
FOX
50
2
TEL
83
-2
Financhill
Back

Pharmaron Beijing 10K Form

Sell
1

PHBBF
Pharmaron Beijing

Last Price:
1.93
Seasonality Move:
--

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PHBBF News And Ratings

See the #1 stock for the next 7 days that we like better than PHBBF

PHBBF Financial Statistics

Sales & Book Value

Annual Sales: $1.53B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $1.24
Price / Book: 0

Profitability

EPS (TTM): 0.18150
Net Income (TTM): $214.73M
Gross Margin: $561.02M
Return on Equity: 13.94%
Return on Assets: 7.37%

Pharmaron Beijing Earnings Forecast

Key Pharmaron Beijing Financial Ratios

  • The Gross Profit Margin over the past 9 years for PHBBF is 36.71%.
  • The Selling, General & Administrative Expenses for PHBBF have been equal to 9.44% of Gross Profit Margin.
  • The Research & Development expenses have been 2.75% of Revenue.
  • The Interest Expense is 12.17% of Operating Income.
  • The Net Earning history of PHBBF is 13.39% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 5 years.

Pharmaron Beijing Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: PHBBF
Website: pharmaron.com

Debt

Debt-to-Equity Ratio: 0.49
Current Ratio: 1.67
Quick Ratio: 1.3

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PHBBF Technical Analysis vs Fundamental Analysis

Sell
1
Pharmaron Beijing (PHBBF) is a Sell

Is Pharmaron Beijing a Buy or a Sell?